Co-treatment with grape seed extract and mesenchymal stem cells in vivo regenerated beta cells of islets of Langerhans in pancreas of type I-induced diabetic rats
Loading...
Date
2022-12
Journal Title
Journal ISSN
Volume Title
Type
Article
Publisher
BioMed Central Ltd.
Series Info
Stem Cell Research & Therapy;(2022) 13:528
Scientific Journal Rankings
Abstract
Background: Nowadays, diabetes mellitus is known as a silent killer because individual is not aware that he has the
disease till the development of its complications. Many researchers have studied the use of stem cells in treatment of
both types of diabetes. Mesenchymal stem cells (MSCs) hold a lot of potential for regenerative therapy. MSCs migrate
and home at the damaged site, where they can aid in the repair of damaged tissues and restoring their function. Oxi-
dative stress and infammation represent a huge obstacle during MSCs transplantation. Therefore, the present study
aimed to evaluate the role of grape seed extract (GSE) administration during MSCs transplantation in streptozotocin
(STZ)-induced type I diabetes. Furthermore, testing some of GSE components [procyanidins(P)-B1 and P-C1] in con-
junction with MSCs, in vivo, was performed to determine if one of them was more efective in relieving the measured
attributes of diabetes more than the whole GSE.
Methods: Firstly, GSE was prepared from the seeds of Muscat of Alexandria grapes and characterized to identify its
phytochemical components. Experimental design was composed of control group I, untreated diabetic group II, GSE
(300 mg/kg)-treated diabetic group III, MSCs (2× 106
cells/rat)-treated diabetic group IV and GSE (300 mg/kg)/MSCs
(2× 106
cells/rat)-treated diabetic group V. Type I diabetes was induced in rats by intravenous injection with 65 mg/kg
of STZ. Treatment started when fasting blood glucose (FBG) level was more than 200 mg/dl; GSE oral administration
started in the same day after MSCs intravenous injection and continued daily for 30 consecutive days.
Results: The results showed that GSE/MSCs therapy in type I-induced diabetic rats has dramatically managed
homeostasis of glucose and insulin secretion; together with, improvement in levels of infammatory markers and
oxidative stress.
Conclusion: Co-treatment with GSE and MSCs in vivo regenerates beta cells in type I-induced diabetic rats.
Description
Keywords
Diabetes mellitus, GSE, MSC, NF-κB, Glucose, Insulin